Accueil » IMF Long

Innovation Market Fit — Wave4Growth

Programme · Innovation Market Fit

Selling innovations is not like selling a product. Most founders learn this the hard way.

Your technology is real. Your product works. Your demos go well.
But the deals don't close — or take forever.

This is not a pipeline problem.
This is not a messaging problem.

This is a decision problem. And it starts earlier than you think.

Who this is for

You'll recognise yourself
in at least one of these.

Prospects say "impressive" and go silent
Your customer hasn't decided to change yet, and you don't know how to trigger that
You rely on distributors to sell your innovations — and nothing moves
You're selling everything your platform can do — and nobody buys
You're in too many conversations that go nowhere

You're a founder or CEO of a B2B tech company — 1 to 100 people — selling innovations.

We work across:

MedTech DeepTech ICT LifeScience Food Safety Industry

Why innovations don't sell like products

When adopting an innovation, your customer
has two decisions to make.
Most founders only address one.

First decision

Should we change at all?

This is where most founders are absent. Their customer hasn't decided to move — so no budget is opened, no project is launched.

Second decision

Which solution should we choose?

This is where most founders show up — with a demo, a pitch, a proof of concept. Too late.

Selling an innovation is not about being chosen. It's about displacing something that already exists — a process, a habit, a supplier, a way of doing things.

That's a change decision. And change decisions don't happen because your product is better. They happen when the cost of staying the same becomes higher than the cost of moving.

No decision to change No project

→

No project No deal

→

Regardless of how good the demo is

Innovation Market Fit works upstream — on the decision to change.

The programme

Five steps. One objective: crack the code.

Understand what exists

Map your current go-to-market reality — targets, messages, results. Successes and failures. And why. No judgment. Full clarity.

Crack the code

Identify the right target, the right use case, the right change drivers — all in synch. This is the hardest step. And the most valuable.

Target: company type and stakeholders

Use case: how your innovation will actually be consumed by the target customer

Change drivers: why change at all, why now, and what makes this decision feel complex or risky for your target customer

Build the value propositions

One per key stakeholder — because in complex B2B, there are multiple people to convince, and each one needs a reason that is theirs.

Test in the field

Real conversations. Real feedback. We adjust until it works.

Prepare for scale

Prospecting approach, entry offer, proof of value design. Ready to deploy.

10 to 12 weeks · Co-built with you, not delivered at you.

What changes

Three founders. Three moments where everything shifted.

HealthTech · AI personalised engagement platform

Ziwig built a platform that does something rare: it understands who you are, what matters to you right now, and builds a step-by-step personalised journey to help you get there.

The business model: sell the platform to leading players so they can leverage it to build a community of customers. For instance, a leading fitness chain could deploy it to support people who want to exercise more — every user getting a highly personalised diagnostic and development plan.

The platform could cope with any type of user community. Which created an immediate problem: too many possible use cases, too many markets, too many potential buyers. Impressive effort, many meetings. No decisions.

The work: a progressive focus, resisted at every step.

All life imperatives → Health → Chronic conditions → Endometriosis

At each step: but we could also serve… At each step: yes. And not now.

One disease. One market. One undeniable pain — 1 woman in 10 affected, 7 to 10 years to diagnosis, no non-invasive solution existing. EndoZiwig was born. EndoTest followed shortly after.

With that focus, everything changed.
Prix Galien International 2024 · Reimbursed by French social security · 100 expert centres · 37 countries · €50M raised

— Yahya El Mir, Founder & President, Ziwig Health

MedTech · Complex wound care

A nurse changes a dressing. Complex wound. Alone. A few days of training — no more. That moment can turn a 4-day hospital stay into 15. Sometimes an amputation.

The founder had built the solution: a full platform — calibrated photos, 3D tracking, bacterial detection, AI diagnostics, and a collaboration tool connecting every caregiver around the patient. An 8-person dev team working out of his attic.

Full platform demo to hospitals. Interest everywhere. Orders nowhere. Two problems: pitching a roadmap instead of what was ready to sell now. And hospitals hadn't decided to change their care protocol yet.

Two pivots: sell only what exists today — the collaboration platform, the one that directly solves the real problem: the nurse who is alone. And replace the pitch with a structured Proof of Value — users in, feedback quantified, business case built from the inside.

3 hospitals engaged · 2 full deployments within 12 months
And somewhere — nurses who are no longer alone.

— MedTech, Belgium

Food Safety Tech · Twenty years of market leadership

Twenty years building a market no one understood better. Then three years where the new innovations stop landing. The rest of the business runs fine. But nothing new takes off.

Two days in. Three problems. Visible immediately.

Some innovations weren't products yet — betas dressed as commercial offers. The market wasn't ready to buy because the product wasn't ready to be sold.

The new innovations asked customers to change their practices. That's not the same decision as buying a product. Not the same timeline. Not the same commercial work.

And to sell these innovations, the company was counting on its existing distributors. Structurally impossible. A distributor can sell a product the market is already waiting for. Not a change of practice.

Three decisions: one product pulled back into development — sales team refocused. One product with early direct wins repositioned with specialist distributors — not economically justifiable to scale direct with a single product and no full range. For the remaining innovations: a new go-to-market — direct to key accounts and KOLs to build the decision to change, distributors to scale after.

First direct wins confirmed · Hybrid go-to-market deployed · Innovation pipeline unblocked

— Food Safety Tech, Belgium

Conditions

This is not a
consulting retainer.
It's a structured
engagement.

Innovation Market Fit is co-built with you and the key people you choose to involve — intensive, focused, and designed to produce commercial traction, not a document.

Duration 10 to 12 weeks
Format Direct work with you and the key people you choose to involve
Availability Maximum 3 projects per quarter

Why the limit? Because this only works with full attention on both sides.

3 projects per quarter.
Is one of them yours?

Connect on LinkedIn → info@wave4growth.com

Selling innovations is not like selling a product. Most founders learn this the hard way.

You'll recognise yourselfin at least one of these.

When adopting an innovation, your customerhas two decisions to make.Most founders only address one.